amiodarone has been researched along with Carcinoma, Papillary in 3 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Carcinoma, Papillary: A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of amiodarone-induced thyrotoxicosis (AIT) concomitant with thyroid cancer in multinodular goiter (MNG)." | 7.78 | Amiodarone-induced thyrotoxicosis with thyroid papillary cancer in multinodular goiter: case report. ( Akamizu, T; Inaba, H; Kobayashi, S; Komatsu, M; Suzuki, S; Takeda, T, 2012) |
| " Administration of amiodarone for atrial fibrillation led to the development of hyperthyroidism." | 7.73 | Amiodarone-induced hyperthyroidism in a patient with functioning papillary carcinoma of the thyroid and extensive hepatic metastases. ( Mackie, GC; Shulkin, BL, 2005) |
| "To report a case of amiodarone-induced thyrotoxicosis (AIT) concomitant with thyroid cancer in multinodular goiter (MNG)." | 3.78 | Amiodarone-induced thyrotoxicosis with thyroid papillary cancer in multinodular goiter: case report. ( Akamizu, T; Inaba, H; Kobayashi, S; Komatsu, M; Suzuki, S; Takeda, T, 2012) |
| " Administration of amiodarone for atrial fibrillation led to the development of hyperthyroidism." | 3.73 | Amiodarone-induced hyperthyroidism in a patient with functioning papillary carcinoma of the thyroid and extensive hepatic metastases. ( Mackie, GC; Shulkin, BL, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inaba, H | 1 |
| Suzuki, S | 1 |
| Takeda, T | 1 |
| Kobayashi, S | 1 |
| Akamizu, T | 1 |
| Komatsu, M | 1 |
| Mackie, GC | 1 |
| Shulkin, BL | 1 |
| Cattaneo, F | 1 |
3 other studies available for amiodarone and Carcinoma, Papillary
| Article | Year |
|---|---|
Amiodarone-induced thyrotoxicosis with thyroid papillary cancer in multinodular goiter: case report.
Topics: Amiodarone; Anti-Arrhythmia Agents; Carcinoma; Carcinoma, Papillary; Goiter, Nodular; Humans; Male; | 2012 |
Amiodarone-induced hyperthyroidism in a patient with functioning papillary carcinoma of the thyroid and extensive hepatic metastases.
Topics: Aged; Amiodarone; Carcinoma, Papillary; Humans; Hyperthyroidism; Liver Neoplasms; Male; Thyroid Neop | 2005 |
Type II amiodarone-induced thyrotoxicosis and concomitant papillary cancer of the thyroid.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Carcinoma, Papillary; Cardiomyopathy, | 2000 |